The article discusses the critical shortages of Creon, a vital pancreatic enzyme replacement therapy used by over 61,000 patients in the UK, including those suffering from pancreatic cancer and cystic fibrosis. Shortages may persist until 2026, forcing patients to travel long distances to find pharmacies with supplies. The Department of Health and Social Care is collaborating with health bodies to resolve these issues. Patients like Diana Gibbs express deep concern, as the lack of medication impacts their ability to digest food, lose weight, and manage essential treatments, raising fears for their health and survival.
"Creon, a pancreatic enzyme replacement therapy, has faced crippling shortages, affecting over 61,000 patients in the UK and is expected to last until 2026."
"Without the drug, patients lose weight and strength, which severely hampers their ability to cope with critical treatments like chemotherapy."
Collection
[
|
...
]